|
PSMD6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78969999931056E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.97310000005224E-06 |
| Normal-vs-Stage2 |
2.460100E-03 |
| Normal-vs-Stage3 |
8.989000E-04 |
| Normal-vs-Stage4 |
5.93540000037862E-07 |
| Stage1-vs-Stage2 |
4.862200E-01 |
| Stage1-vs-Stage3 |
3.624000E-01 |
| Stage1-vs-Stage4 |
1.899350E-01 |
| Stage2-vs-Stage3 |
9.281200E-01 |
| Stage2-vs-Stage4 |
4.373200E-01 |
| Stage3-vs-Stage4 |
5.183400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88460000330559E-09 |
| Normal-vs-AfricanAmerican |
7.896700E-03 |
| Normal-vs-Asian |
2.348400E-01 |
| Caucasian-vs-AfricanAmerican |
8.492300E-02 |
| Caucasian-vs-Asian |
8.799000E-01 |
| AfricanAmerican-vs-Asian |
6.784400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.66360045131364E-10 |
| Normal-vs-Female |
5.273700E-02 |
| Male-vs-Female |
4.123000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.379000E-04 |
| Normal-vs-Extreme_Weight |
1.91859999998378E-07 |
| Normal-vs-Obese |
9.76059999999723E-05 |
| Normal-vs-Extreme_Obese |
1.912250E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.525400E-01 |
| Normal_Weight-vs-Obese |
9.134800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.890600E-01 |
| Extreme_Weight-vs-Obese |
5.383600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.935800E-01 |
| Obese-vs-Extreme_Obese |
9.361000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.064100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.65159999998554E-06 |
| Normal-vs-Age(61-80Yrs) |
7.17899999447269E-08 |
| Normal-vs-Age(81-100Yrs) |
2.314100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.104600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.261600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.886800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.807400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.677000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.868400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.54799999999566E-05 |
| Normal-VS-Type2 PRCC |
1.14690000052597E-07 |
| Normal-VS-KIRP CIMP |
1.316990E-03 |
| Normal-VS-Unclassified PRCC |
1.164930E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.610450E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.578400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.170000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.057000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.925400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.889600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.35999999939918E-08 |
| Normal-vs-N1 |
1.751290E-04 |
| Normal-vs-N2 |
2.47689999954837E-07 |
| N0-vs-N1 |
4.719400E-01 |
| N0-vs-N2 |
1.947200E-01 |
| N1-vs-N2 |
6.767800E-02 |
|
|
